Highlights and Quick Summary
- Beginning Cash for the quarter ending September 30, 2022 was $0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Beginning Cash decreased by NaN%
- Annual Beginning Cash for 2021 was $62.3 Million (a 1039.47% increase from previous year)
- Annual Beginning Cash for 2020 was $5.47 Million (a -10.27% decrease from previous year)
- Twelve month Beginning Cash ending September 30, 2022 was $32.8 Million (a 0.0% decrease compared to previous quarter)
- Twelve month trailing Beginning Cash decreased by -47.36% year-over-year
Trailing Beginning Cash for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $32.8 Million | $32.8 Million | $32.8 Million | $62.3 Million |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Beginning Cash of Biodesix, Inc.
Most recent Beginning Cashof BDSX including historical data for past 10 years.Interactive Chart of Beginning Cash of Biodesix, Inc.
Biodesix, Inc. Beginning Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.0 | $0.0 | $32.8 | – |
| 2021 | $0.0 | $0.0 | $0.0 | $62.31 | $62.31 |
| 2020 | $-0.0 | $0.0 | $0.0 | $5.47 | $5.47 |
| 2019 | $0.0 | $6.09 | – | – | $6.09 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research